Back to Search
TERRENCE O'HARE, D.M.D.
D.M.D.
General Practice Dentistry
NPI: 1255351649Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
33132(CA)
Research & Publications (20)
SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib.
PMID 18367669·Proc Natl Acad Sci U S A·2008
8-other
New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check.
PMID 18491988·Expert Opin Investig Drugs·2008
6-review
Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia.
PMID 17496200·Blood·2007
7-preclinical
Bcr-Abl kinase domain mutations and the unsettled problem of Bcr-AblT315I: looking into the future of controlling drug resistance in chronic myeloid leukemia.
PMID 17382021·Clin Lymphoma Myeloma·2007
6-review
Targeted CML therapy: controlling drug resistance, seeking cure.
PMID 16343892·Curr Opin Genet Dev·2006
6-review
Combined Abl inhibitor therapy for minimizing drug resistance in chronic myeloid leukemia: Src/Abl inhibitors are compatible with imatinib.
PMID 16203792·Clin Cancer Res·2005
7-preclinical
In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants.
PMID 15930265·Cancer Res·2005
7-preclinical
Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML.
PMID 15256422·Blood·2004
8-other
Single particle quantum dot imaging achieves ultrasensitive detection capabilities for Western immunoblot analysis.
PMID 19453141·ACS Nano·2009
8-other
Functional characterization of an activating TEK mutation in acute myeloid leukemia: a cellular context-dependent activating mutation.
PMID 19340004·Leukemia·2009
8-other
RNAi screen for rapid therapeutic target identification in leukemia patients.
PMID 19433805·Proc Natl Acad Sci U S A·2009
8-other
Epithiospecifier protein activity in broccoli: the link between terminal alkenyl glucosinolates and sulphoraphane nitrile.
PMID 18977005·Phytochemistry·2008
8-other
Growth arrest of BCR-ABL positive cells with a sequence-specific polyamide-chlorambucil conjugate.
PMID 18974832·PLoS One·2008
7-preclinical
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.
PMID 18025156·Blood·2008
8-other
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.
PMID 18559973·Blood·2008
7-preclinical
Persistent LYN signaling in imatinib-resistant, BCR-ABL-independent chronic myelogenous leukemia.
PMID 18577744·J Natl Cancer Inst·2008
8-other
New strategies for the first-line treatment of chronic myeloid leukemia: can resistance be avoided?
PMID 19254881·Clin Lymphoma Myeloma·2008
6-review
Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.
PMID 16880519·Mol Cell Biol·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5 W D ST
LEMOORE, CA 93245 - Phone
- (559) 924-2206
Quick Facts
- NPI
- 1255351649
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile